Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 PORTERS FIVES FORCES
6 PESTEL ANALYSIS
7 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: REGULATIONS
7.1 REGULATION IN THE U.S.
7.2 REGULATION IN EUROPE:
7.3 REGULATIONS IN CHINA
7.4 MEDICAL DEVICE INSTRUCTIONS:
7.5 REGULATIONS IN JAPAN
7.6 REGULATION IN INDIA
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASED INCIDENCE OF CHRONIC DISEASES
8.1.2 SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASE
8.1.3 INCREASED IMPLEMENTATION OF FLUOROSPOT ASSAY
8.1.4 USE OF KITS FOR VACCINE RESEARCH TO OVERCOME THE DRUG RESISTANCE
8.1.5 USE OF ELISPOT AND FLUOROSPOT ASSAY FOR CLINICAL TRIALS
8.2 RESTRAINTS
8.2.1 RISE IN COST OF THE ELISPOT AND FLUOROSPOT DETECTION KITS
8.2.2 AVAILABILITY OF ALTERNATE DETECTION KITS
8.2.3 LESS AVAILABILITY OF HIGH-QUALITY DETECTION REAGENTS
8.2.4 COMPLEXITY IN ELISPOT AND FLUOROSPOT ASSAY
8.3 OPPORTUNITIES
8.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
8.3.2 RISING NUMBER OF IN-VITRO DIAGNOSTIC TESTS
8.3.3 RISING HEALTHCARE EXPENDITURE
8.3.4 INCREASING RESEARCH AND DEVELOPMENT
8.4 CHALLENGES
8.4.1 STRINGENT RULES & REGULATIONS
8.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS
8.4.3 RISING COMPETITION BETWEEN MARKET PLAYERS
9 IMPACT OF COVID-19 ON THE EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS BY MANUFACTURERS
9.5 CONCLUSION
10 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE
10.1 OVERVIEW
10.2 ASSAY KIT
10.2.1 T-CELL ASSAY
10.2.2 B-CELL ASSAY
10.3 SUPPLEMENTARY/ANCILLARY PRODUCTS
10.4 ANALYZERS
11 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE
11.1 OVERVIEW
11.2 HUMAN
11.3 MOUSE
11.4 MONKEY
11.5 OTHERS
12 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE
12.1 OVERVIEW
12.2 INFECTIOUS DISEASE
12.2.1 INFLUENZA
12.2.2 HIV
12.2.3 COVID-19
12.2.4 OTHERS
12.3 CANCER
12.4 AUTOIMMUNE DISEASE
12.5 ALLERGY
12.6 OTHER
13 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 DIAGNOSTIC APPLICATION
13.2.1 INFECTIOUS DISEASES
13.2.2 TRANSPLANTS
13.2.3 OTHERS
13.3 RESEARCH APPLICATION
13.3.1 CLINICAL TRIALS
13.3.2 CANCER RESEARCH
13.3.3 VACCINE DEVELOPMENT
13.3.4 OTHERS
14 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS & CLINICAL LABORATORIES
14.3 RESEARCH INSTITUTES
14.4 BIOPHARMACEUTICAL COMPANIES
14.5 OTHERS
15 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 RETAIL SALES
15.3 DIRECT TENDER
16 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION
16.1 EUROPE
16.1.1 GERMANY
16.1.2 U.K.
16.1.3 FRANCE
16.1.4 ITALY
16.1.5 SPAIN
16.1.6 NETHERLANDS
16.1.7 SWITZERLAND
16.1.8 RUSSIA
16.1.9 BELGIUM
16.1.10 TURKEY
16.1.11 REST OF EUROPE
17 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: EUROPE
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 BD
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 OXFORD IMMUNOTEC USA, INC. (A SUBSIDIARY OF PERKINELMER INC.)
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 R&D SYSTEMS, INC.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 MABTECH
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENTS
19.5 THERMO FISHER SCIENTIFIC INC.
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 ABCAM PLC
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 AUTOIMMUN DIAGNOSTIKA GMBH
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 CELLCARTA
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENTS
19.9 CELLULAR TECHNOLOGY LIMITED (CTL)
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT
19.1 COVANCE INC. (A SUBSIDIARY OF LABCORP DRUG DEVELOPMENT)
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 COVALAB, INC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENTS
19.12 DIACLONE SAS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENTS
19.13 MIKROGEN GMBH
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 OXFORD BIOSYSTEMS LTD.
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 U-CYTECH
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
List of Table
TABLE 1 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 EUROPE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 EUROPE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 EUROPE SUPPLEMENTARY/ANCILLARY PRODUCTS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 EUROPE ANALYZERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 7 EUROPE HUMAN IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 EUROPE MOUSE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 EUROPE MONKEY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 EUROPE OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 12 EUROPE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 EUROPE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 14 EUROPE CANCER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 EUROPE AUTOIMMUNE DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 EUROPE ALLERGY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 EUROPE OTHER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 EUROPE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 21 EUROPE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 23 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 24 EUROPE HOSPITALS & CLINICAL LABORATORIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE RESEARCH INSTITUTES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 EUROPE BIOPHARMACEUTICAL COMPANIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 EUROPE OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 29 EUROPE RETAIL SALES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE DIRECT TENDER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 33 EUROPE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 34 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 35 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 36 EUROPE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 37 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 38 EUROPE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 EUROPE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 41 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 42 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 43 GERMANY ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 44 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 45 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 46 GERMANY INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 47 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 GERMANY DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 GERMANY RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 52 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 U.K. ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 55 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 56 U.K. INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 57 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 U.K. DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 U.K. RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 61 U.K. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 62 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 FRANCE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 65 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 66 FRANCE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 67 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 FRANCE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 FRANCE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 70 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 71 FRANCE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 72 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 ITALY ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 74 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 75 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 76 ITALY INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 77 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 ITALY DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 79 ITALY RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 80 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 81 ITALY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 82 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 83 SPAIN ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 84 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 85 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 86 SPAIN INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 87 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 88 SPAIN DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 89 SPAIN RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 90 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 SPAIN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 92 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 93 NETHERLANDS ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 94 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 95 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 96 NETHERLANDS INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 97 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 NETHERLANDS DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 NETHERLANDS RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 100 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 101 NETHERLANDS ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 102 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 103 SWITZERLAND ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 105 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 106 SWITZERLAND INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 107 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 108 SWITZERLAND DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 SWITZERLAND RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 111 SWITZERLAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 112 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 RUSSIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 114 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 115 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 116 RUSSIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 117 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 118 RUSSIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 119 RUSSIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 120 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 121 RUSSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 122 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 123 BELGIUM ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 124 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 125 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 126 BELGIUM INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 127 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 128 BELGIUM DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 BELGIUM RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 BELGIUM ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 132 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 133 TURKEY ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 134 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 135 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 136 TURKEY INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION)
TABLE 137 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 138 TURKEY DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 139 TURKEY RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 140 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 141 TURKEY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION)
TABLE 142 REST OF EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION
FIGURE 2 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION
FIGURE 11 INCREASED INCIDENCE OF CHRONIC DISEASES AND SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASES ARE EXPECTED TO DRIVE THE EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ASSAY KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET
FIGURE 14 PREVALENCE OF CHRONIC DISEASES DURING THE COVID-19 PANDEMIC
FIGURE 15 EUROPE INCIDENCE OF KAWASAKI SYNDROME PER 100,000 CHILDREN UNDER 5 YEARS OF AGE
FIGURE 16 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 17 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2020
FIGURE 18 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2019-2028 (USD MILLION)
FIGURE 19 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 20 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2020
FIGURE 22 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2019-2028 (USD MILLION)
FIGURE 23 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, CAGR (2021-2028)
FIGURE 24 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 25 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2020
FIGURE 26 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2019-2028 (USD MILLION)
FIGURE 27 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, CAGR (2021-2028)
FIGURE 28 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 29 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2020
FIGURE 30 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 31 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2020
FIGURE 34 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 35 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 36 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 38 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 39 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 40 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020)
FIGURE 42 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020)
FIGURE 43 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 44 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 45 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 46 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%)
